Skip to main content
Year archive

INVION LIMITED — 2025 filings

All 86 regulatory filings released by INVION LIMITED (IVX) in 2025, sourced directly from the official regulator.

86 Filings
2025 Period
2025 filings (86)
Filing Released Lang
Hanlim & Korean Government Fund Pathway to Clinical Trial 3 pages 221.3KB
Capital/Financing Update
2025-12-22 English
Invion Secures Expanded Photosoft Global Exclusive License 14 pages 261.0KB
Capital/Financing Update
2025-12-02 English
AGM Presentation 15 pages 1.4MB
AGM Information
2025-11-25 English
Results of Annual General Meeting 2 pages 223.8KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-25 English
Appendix 4C and Quarterly Activities Report - September 2025 9 pages 359.8KB
Interim / Quarterly Report
2025-10-30 English
Notification regarding unquoted securities - IVX 7 pages 22.2KB
Share Issue/Capital Change
2025-10-30 English
Notice of Annual General Meeting/Proxy Form 38 pages 1.3MB
AGM Information
2025-10-23 English
Funded Collaboration Agreement with Protect Animal Health 3 pages 231.2KB
Capital/Financing Update
2025-10-20 English
Repayment of Lind Facility with Successful Capital Raise 3 pages 182.2KB
Capital/Financing Update
2025-10-09 English
Proposed issue of securities - IVX 6 pages 20.9KB
Capital/Financing Update
2025-10-09 English
Proposed issue of securities - IVX 5 pages 17.5KB
Capital/Financing Update
2025-10-09 English
Trading Halt 2 pages 205.7KB
Regulatory Filings
2025-10-07 English
Notification of cessation of securities - IVX 5 pages 16.0KB
Share Issue/Capital Change
2025-09-23 English
Change of Director's Interest Notice - Thian Chew 3 pages 218.4KB
Director's Dealing
2025-09-23 English
Response to ASX Aware Letter 6 pages 413.8KB
Regulatory Filings
2025-08-27 English
Appendix 4E and Annual Report 54 pages 2.4MB
Annual Report
2025-08-26 English
Appendix 4G and Corporate Governance Statement 22 pages 694.1KB
Governance Information
2025-08-26 English
Response to ASX Price Query 4 pages 288.0KB
Regulatory Filings
2025-08-19 English
Orphan Drug Designation Granted by U.S. FDA For Anal Cancer 3 pages 253.4KB
Regulatory Filings
2025-08-19 English
Application for quotation of securities - IVX 6 pages 18.3KB
Share Issue/Capital Change
2025-08-19 English
Notification regarding unquoted securities - IVX 7 pages 22.2KB
Share Issue/Capital Change
2025-08-19 English
Pause in Trading 1 page 115.6KB
Regulatory Filings
2025-08-18 English
Trading Halt 2 pages 292.8KB
Regulatory Filings
2025-08-18 English
Application for quotation of securities - IVX 6 pages 18.5KB
Share Issue/Capital Change
2025-08-13 English
Section 708A Cleansing Statement 2 pages 205.1KB
Regulatory Filings
2025-08-13 English
Application for quotation of securities - IVX 6 pages 18.3KB
Share Issue/Capital Change
2025-08-07 English
Appendix 4C and Quarterly Activities Report - June 2025 8 pages 256.9KB
Interim / Quarterly Report
2025-07-30 English
Notification regarding unquoted securities - IVX 7 pages 22.1KB
Share Issue/Capital Change
2025-07-28 English
Application for quotation of securities - IVX 6 pages 18.3KB
Capital/Financing Update
2025-07-23 English
Change of Director's Interest Notice - Thian Chew 3 pages 244.0KB
Director's Dealing
2025-07-23 English
Change of Director's Interest Notice - Alan Yamashita 2 pages 240.7KB
Director's Dealing
2025-07-23 English
Change of Director's Interest Notice - Alistair Bennallack 2 pages 240.5KB
Director's Dealing
2025-07-23 English
Application for quotation of securities - IVX 7 pages 24.2KB
Capital/Financing Update
2025-07-23 English
IVX Option Entitlement Offer Distribution Schedule & Top 20 3 pages 166.2KB
Regulatory Filings
2025-07-16 English
Application for quotation of securities - IVX 5 pages 16.8KB
Share Issue/Capital Change
2025-07-16 English
Security Class Reinstatement to Quotation 1 page 13
Regulatory Filings
2025-07-16 English
Invion Announces Results of Entitlement Offer 2 pages 218.8KB
Regulatory Filings
2025-07-14 English
Security Class Suspension from Quotation 1 page 105
Delisting Announcement
2025-07-10 English
Entitlement Offer Opens and Completion of Despatch 2 pages 222.7KB
Capital/Financing Update
2025-06-30 English
Section 708A Cleansing Statement 2 pages 206.4KB
Regulatory Filings
2025-06-24 English
Change of Director's Interest Notice - Alistair Bennallack 2 pages 241.7KB
Director's Dealing
2025-06-24 English
Change of Director's Interest Notice - Alan Yamashita 2 pages 241.4KB
Director's Dealing
2025-06-24 English
Change of Director's Interest Notice - Thian Chew 2 pages 242.6KB
Director's Dealing
2025-06-24 English
Update - Proposed issue of securities - IVX 7 pages 25.9KB
Capital/Financing Update
2025-06-23 English
Application for quotation of securities - IVX 6 pages 18.5KB
Share Issue/Capital Change
2025-06-23 English
Underwritten Loyalty Option Entitlement Offer Prospectus 5 pages 200.9KB
Capital/Financing Update
2025-06-22 English
Options Entitlement Offer Prospectus 44 pages 806.7KB
Capital/Financing Update
2025-06-22 English
Options Entitlement Offer-Letter to Ineligible Shareholders 3 pages 179.8KB
Capital/Financing Update
2025-06-22 English
Options Entitlement Offer - Letter to Option Holders 3 pages 166.7KB
Capital/Financing Update
2025-06-22 English
Options Entitlement Offer - Target Market Determination 5 pages 204.3KB
Regulatory Filings
2025-06-22 English
Proposed issue of securities - IVX 7 pages 26.0KB
Capital/Financing Update
2025-06-22 English
Loyalty Option Entitlement Offer 4 pages 206.3KB
Capital/Financing Update
2025-06-12 English
Notice Under Section 708A(9)(c) of the Corporations Act 2 pages 168.2KB
Capital/Financing Update
2025-06-10 English
Response to ASX Cleansing Notice Timing Letter 8 pages 520.6KB
Regulatory Filings
2025-06-10 English
Investor Presentation - June 2025 29 pages 3.0MB
Investor Presentation
2025-06-03 English
Change of Registered Office Address 1 page 193.7KB
Regulatory Filings
2025-06-01 English
Encouraging SRC Findings on Ph I/II Skin Cancer Trial 4 pages 380.8KB
Regulatory Filings
2025-05-28 English
Application for quotation of securities - IVX 6 pages 18.3KB
Share Issue/Capital Change
2025-05-26 English
Notification regarding unquoted securities - IVX 6 pages 20.8KB
Share Issue/Capital Change
2025-05-26 English
Section 708A Cleansing Statement 2 pages 205.6KB
Capital/Financing Update
2025-05-26 English
Update - Notification regarding unquoted securities - IVX 6 pages 18.6KB
Share Issue/Capital Change
2025-05-14 English
Notification regarding unquoted securities - IVX 6 pages 18.7KB
Share Issue/Capital Change
2025-05-13 English
Results of Extraordinary General Meeting 3 pages 246.5KB
Declaration of Voting Results & Voting Rights Announcements
2025-05-08 English
Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial 2 pages 227.1KB
Regulatory Filings
2025-05-01 English
Appendix 4C and Quarterly Activities Report - March 2025 8 pages 292.9KB
Interim / Quarterly Report
2025-04-29 English
Notice of Extraordinary General Meeting/Proxy Form 30 pages 1.4MB
Proxy Solicitation & Information Statement
2025-04-07 English
Application for quotation of securities - IVX 6 pages 18.4KB
Share Issue/Capital Change
2025-03-31 English
Section 708A Cleansing Statement 2 pages 203.3KB
Regulatory Filings
2025-03-31 English
Application for quotation of securities - IVX 6 pages 18.5KB
Share Issue/Capital Change
2025-03-12 English
Section 708A Cleansing Statement 2 pages 204.0KB
Capital/Financing Update
2025-03-12 English
Update - Proposed issue of securities - IVX 6 pages 22.2KB
Capital/Financing Update
2025-03-10 English
Share Purchase Agreement Termination and Tranche Repayment 2 pages 195.7KB
Capital/Financing Update
2025-03-04 English
Cancel - Application for quotation of securities - IVX 6 pages 18.1KB
Capital/Financing Update
2025-03-04 English
Completion Of Placement to Accelerate Clinical Programs 3 pages 242.4KB
Capital/Financing Update
2025-03-03 English
Proposed issue of securities - IVX 6 pages 22.1KB
Capital/Financing Update
2025-03-03 English
Application for quotation of securities - IVX 6 pages 18.5KB
Share Issue/Capital Change
2025-03-03 English
Section 708A Cleansing Statement 2 pages 203.8KB
Capital/Financing Update
2025-03-03 English
Trading Halt 2 pages 587.7KB
Regulatory Filings
2025-02-27 English
Appendix 4D and Half Year Financial Report 22 pages 1.1MB
Interim / Quarterly Report
2025-02-27 English
Oesophageal Cancer Collaboration and Funding Agreement 3 pages 245.7KB
Capital/Financing Update
2025-02-25 English
Activities Report and Appendix 4C 9 pages 320.3KB
Interim / Quarterly Report
2025-01-30 English
Application for quotation of securities - IVX 6 pages 18.4KB
Share Issue/Capital Change
2025-01-22 English
Section 708A Cleansing Statement 2 pages 202.3KB
Regulatory Filings
2025-01-22 English
Notification regarding unquoted securities - IVX 7 pages 21.3KB
Share Issue/Capital Change
2025-01-13 English
Application for quotation of securities - IVX 6 pages 18.4KB
Share Issue/Capital Change
2025-01-01 English
Section 708A Cleansing Statement 2 pages 194.5KB
Regulatory Filings
2025-01-01 English